These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15910630)

  • 1. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.
    Oomen PH; van Tol A; Hattori H; Smit AJ; Scheek LM; Dullaart RP
    Diabet Med; 2005 Jun; 22(6):768-74. PubMed ID: 15910630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans.
    Blümer RM; van der Crabben SN; Stegenga ME; Tanck MW; Ackermans MT; Endert E; van der Poll T; Sauerwein HP
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E613-7. PubMed ID: 18577692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of leptin, adiponectin and acylation-stimulating protein by hyperinsulinaemia and hyperglycaemia in vivo in healthy lean young men.
    Faraj M; Beauregard G; Tardif A; Loizon E; Godbout A; Cianflone K; Vidal H; Rabasa-Lhoret R
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):334-42. PubMed ID: 18562232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effects of acute hyperglycaemia and hyperinsulinaemia on skin microcirculation and endothelial markers in Type II diabetes mellitus.
    Oomen PH; Kant GD; Dullaart RP; Tervaert JW; Reitsma WD; Smit AJ
    Scand J Clin Lab Invest; 2004 Apr; 64(2):119-27. PubMed ID: 15115249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men.
    Van Tol A; Ligtenberg JJ; Riemens SC; van Haeften TW; Reitsma WD; Dullaart RP
    Scand J Clin Lab Invest; 1997 Apr; 57(2):147-57. PubMed ID: 9200274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus.
    Singh A; Boden G; Rao AK
    Thromb Haemost; 2015 Apr; 113(4):750-8. PubMed ID: 25653143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
    Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
    Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
    Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre beta-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients.
    De Vries R; Beusekamp BJ; Kerstens MN; Groen AK; Van Tol A; Dullaart RP
    Scand J Clin Lab Invest; 2005; 65(8):729-37. PubMed ID: 16319046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo.
    Ooi EM; Watts GF; Ji J; Rye KA; Johnson AG; Chan DC; Barrett PH
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):752-9. PubMed ID: 17121526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.
    Suskin N; McKelvie RS; Burns RJ; Latini R; Pericak D; Probstfield J; Rouleau JL; Sigouin C; Solymoss CB; Tsuyuki R; White M; Yusuf S
    Eur Heart J; 2000 Aug; 21(16):1368-75. PubMed ID: 10952826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid transfer protein is present in human tear fluid.
    Jauhiainen M; Setälä NL; Ehnholm C; Metso J; Tervo TM; Eriksson O; Holopainen JM
    Biochemistry; 2005 Jun; 44(22):8111-6. PubMed ID: 15924430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus.
    Attia N; Domingo N; Lorec AM; Nakbi A; Hammami S; Ben Hamda K; Portugal H; Lairon D; Hammami M; Chanussot F
    Clin Biochem; 2009 Jun; 42(9):845-51. PubMed ID: 19135989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute hyperglycaemia on sodium handling and excretion of nitric oxide metabolites, bradykinin, and cGMP in Type 1 diabetes mellitus.
    Simková R; Kazdová L; Karasová L; Simek S; Pelikánová T
    Diabet Med; 2004 Sep; 21(9):968-75. PubMed ID: 15317600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro.
    Assert R; Scherk G; Bumbure A; Pirags V; Schatz H; Pfeiffer AF
    Diabetologia; 2001 Feb; 44(2):188-95. PubMed ID: 11270675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice.
    Fiedler M; Zierath JR; Selén G; Wallberg-Henriksson H; Liang Y; Sakariassen KS
    Diabetologia; 2001 Dec; 44(12):2180-6. PubMed ID: 11793019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
    Watts GF; Ji J; Chan DC; Ooi EM; Johnson AG; Rye KA; Barrett PH
    Clin Sci (Lond); 2006 Sep; 111(3):193-9. PubMed ID: 16700661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early decreases in plasma lipid transfer proteins during weight reduction.
    Tzotzas T; Dumont L; Triantos A; Karamouzis M; Constantinidis T; Lagrost L
    Obesity (Silver Spring); 2006 Jun; 14(6):1038-45. PubMed ID: 16861609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to metabolic signals in late-gestation growth-restricted fetuses from rapidly growing adolescent sheep.
    Wallace JM; Milne JS; Aitken RP; Hay WW
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1233-41. PubMed ID: 17711986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.